Spectranetics' Extreme 0.9mm catheter gains PMA supplement:
This article was originally published in Clinica
Spectranetics has obtained FDA approval for its application to market the Extreme 0.9mm disposable catheter for laser coronary angioplasty. The catheter is designed to remove blockages in small coronary vessels that are hard to reach. The company of Colorado Springs, Colorado, plans only a limited release of the product in the two months before a full launch in October.